Headquartered in Texas, MicroTransponder Inc. has developed the Paired Vagus Nerve Stimulation (Paired VNS™) platform; the Vivistim® system is the first FDA-approved system on the platform for treatment of post-stroke upper limb impairment.
Developer of an implantable neurostimulation device designed to aid stroke recovery, and other neurological disorders. The company's device incorporates paired vagus nerve stimulation and wireless technology to deliver targeted electrical impulses, enhancing neuroplasticity, and restoring motor function in post-stroke patients, enabling healthcare practitioners to improve patient outcomes.
Developer of an intraoperative monitoring platform designed to provide real-time and direct feedback to surgeons regarding potential damage to the nerve and vascular structures during surgeries. The company's tool improves surgical outcomes by monitoring reliability reducing the cost of products and increasing the availability which will allow more surgeries to be monitored, helping clinicians decrease short and long-term healthcare costs and improving the quality of life for patients.